Development of a high-sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS-CoV-2 spike glycoprotein in serum and saliva.
Development of a high-sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS-CoV-2 spike glycoprotein in serum and saliva.
复制标题
血清和唾液SARS-CoV-2刺突糖蛋白IgG、伊加和IgM抗体高灵敏度ELISA检测方法的建立
DOI:
10.1111/imm.13349
复制
发表时间:
2021-09
期刊:
影响因子:
6.4
通讯作者:
Richter AG
中科院分区:
文献类型:
--
作者:
Faustini SE;Jossi SE;Perez-Toledo M;Shields AM;Allen JD;Watanabe Y;Newby ML;Cook A;Willcox CR;Salim M;Goodall M;Heaney JL;Marcial-Juarez E;Morley GL;Torlinska B;Wraith DC;Veenith TV;Harding S;Jolles S;Ponsford MJ;Plant T;Huissoon A;O'Shea MK;Willcox BE;Drayson MT;Crispin M;Cunningham AF;Richter AG
Detecting antibody responses during and after SARS‐CoV‐2 infection is essential in determining the seroepidemiology of the virus and the potential role of antibody in disease. Scalable, sensitive and specific serological assays are essential to this process. The detection of antibody in hospitalized patients with severe disease has proven relatively straightforward; detecting responses in subjects with mild disease and asymptomatic infections has proven less reliable. We hypothesized that the suboptimal sensitivity of antibody assays and the compartmentalization of the antibody response may contribute to this effect. We systematically developed an ELISA, optimizing different antigens and amplification steps, in serum and saliva from non‐hospitalized SARS‐CoV‐2‐infected subjects. Using trimeric spike glycoprotein, rather than nucleocapsid, enabled detection of responses in individuals with low antibody responses. IgG1 and IgG3 predominate to both antigens, but more anti‐spike IgG1 than IgG3 was detectable. All antigens were effective for detecting responses in hospitalized patients. Anti‐spike IgG, IgA and IgM antibody responses were readily detectable in saliva from a minority of RT‐PCR confirmed, non‐hospitalized symptomatic individuals, and these were mostly subjects who had the highest levels of anti‐spike serum antibodies. Therefore, detecting antibody responses in both saliva and serum can contribute to determining virus exposure and understanding immune responses after SARS‐CoV‐2 infection. This manuscript describes the development of a highly sensitive ELISA, optimizing different antigens and amplification steps, in serum and saliva from non‐hospitalized SARS‐CoV‐2‐infected subjects. Using a trimeric spike glycoprotein, rather than nucleocapsid, enabled detection of responses in individuals with mild‐to‐moderate infection. The detection of antibodies in both serum and saliva can contribute to determining virus exposure and understanding immune responses to SARS‐CoV‐2.
登录
查看更多内容
影响因子:
5.4
作者:
Lau, Susanna K. P.;Lee, Paul;Yuen, Kwok-Yung
通讯作者:
Yuen, Kwok-Yung
影响因子:
13.2
作者:
Sun, Baoqing;Feng, Ying;Chen, Ling
通讯作者:
Chen, Ling
影响因子:
2.2
作者:
Mestecky, J;Hamilton, RG;Reimer, CB
通讯作者:
Reimer, CB
影响因子:
24.8
作者:
Isho B;Abe KT;Zuo M;Jamal AJ;Rathod B;Wang JH;Li Z;Chao G;Rojas OL;Bang YM;Pu A;Christie-Holmes N;Gervais C;Ceccarelli D;Samavarchi-Tehrani P;Guvenc F;Budylowski P;Li A;Paterson A;Yue FY;Marin LM;Caldwell L;Wrana JL;Colwill K;Sicheri F;Mubareka S;Gray-Owen SD;Drews SJ;Siqueira WL;Barrios-Rodiles M;Ostrowski M;Rini JM;Durocher Y;McGeer AJ;Gommerman JL;Gingras AC
通讯作者:
Gingras AC
DOI:
10.1093/infdis/jiaa593
发表时间:
2020-11-13
期刊:
The Journal of infectious diseases
影响因子:
--
作者:
Schwaiger J;Karbiener M;Aberham C;Farcet MR;Kreil TR
通讯作者:
Kreil TR